Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. |
| |
Authors: | C R Bangham S E Hall K J Jeffery A M Vine A Witkover M A Nowak D Wodarz K Usuku M Osame |
| |
Affiliation: | Department of Immunology, Imperial College School of Medicine, London, UK. c.bangham@ic.ac.uk |
| |
Abstract: | About 1% of people infected with the human T-cell leukaemia virus, type 1 (HTLV-I) develop a disabling chronic inflammatory disease of the central nervous system known as HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Patients with HAM/TSP have a vigorous immune response to HTLV-I, and it has been widely suggested that this immune response, particularly the HTLV-I-specific cytotoxic T-lymphocyte (CTL) response, causes the tissue damage that is seen in HAM/TSP. In this paper we summarize recent evidence that a strong CTL response to HTLV-I does in fact protect against HAM/TSP by reducing the proviral load of HTLV-I. We conclude that HTLV-I is persistently replicating at a high level, despite the relative constancy of its genome sequence. These results imply that antiretroviral drugs could reduce the risk of HAM/TSP by reducing the viral load, and that an effective anti-HTLV-I vaccine should elicit a strong CTL response to the virus. The dynamic nature of the infection also has implications for the epidemiology and the evolution of HTLV-I. |
| |
Keywords: | |
|
|